Impact of combined acute rejection on BK virus-associated nephropathy in kidney transplantation.

BK virus-associated nephropathy (BKVAN) is one of the major causes of allograft dysfunction in kidney transplant (KT) patients. We compared BKVAN comb...
255KB Sizes 1 Downloads 0 Views

Recommend Documents

BK virus nephropathy complicated with meningoencephalitis after kidney transplantation.
BK disease is an opportunistic infection in organ transplant recipients and patients with other cellular immunodeficiencies. To the best of our knowledge, we report the second case of BK meningoencephalitis associated with nephropathy in a kidney tra

The impact of acute rejection in kidney transplantation on long-term allograft and patient outcome.
Patients with end stage renal disease (ESRD) can be sustained with dialysis therapy.

Acute and chronic antibody-mediated rejection in pediatric kidney transplantation.
Acute antibody-mediated rejection is a diagnostic challenge in renal transplantation medicine. However, it is an important diagnosis to make, since chronic antibody-mediated rejection (CAMR) is the main cause of long-term graft loss. Antibody-mediate

Incidence and impact of rejection following simultaneous liver-kidney transplantation.
Due to hepatic immunoregulation, simultaneous liver-kidney recipients are presumed to be reasonably protected from kidney rejection and typically receive less immunosuppression compared to kidney transplants alone. However, data to support these conc

High impact of rejection therapy on the incidence of post-transplant diabetes mellitus after kidney transplantation.
Although major risk factors for post-transplant diabetes (PTDM) after kidney transplantation have been identified, a systematic study on the impact of rejection and rejection therapy is missing so far.

Characterization of transfusion-elicited acute antibody-mediated rejection in a rat model of kidney transplantation.
Animal models of antibody-mediated rejection (ABMR) may provide important evidence supporting proof of concept. We elicited donor-specific antibodies (DSA) by transfusion of donor blood (Brown Norway RT1(n) ) into a complete mismatch recipient (Lewis

Delayed graft function and the risk of acute rejection in the modern era of kidney transplantation.
Delayed graft function (DGF) is commonly considered a risk factor for acute rejection, although this finding has not been uniformly observed across all studies. The link between DGF and acute rejection may have changed over time due to advances in im